MCST NewsMCST News

Current Articles

Evolence Class Action Commenced

Toronto law firm McPhadden Samac Tuovi announced today that it had commenced a proposed class action against Johnson & Johnson and related companies relative to the collagen dermal filler Evolence.

The Evolence claim involves people who were injected with Evolence and allegedly developed side effects that in some cases included disfiguring nodule formation. It is alleged that Johnson & Johnson and related companies failed to warn the public about the potential of these adverse effects.

The claim is on behalf of all residents of Canada who were injected with Evolence and allege that they suffered injuries and damages.

The amount claimed is $15 million.

Media Release.

For further information and instructions.